Erin D. Michos
Professor of Medicine
Also affiliated: American College of Cardiology (2022); University of Vermont (2016); Northwestern University (2013–2020); Twitter (United States) (2021); University of North Carolina at Chapel Hill (2014); University of Geneva (2016); University of Iowa (2013–2019); American Heart Association (2007–2022); Atrium Health Wake Forest Baptist (2017); Novartis (Switzerland) (2023); Lahey Hospital and Medical Center (2022); Houston Methodist (2017–2020); National Institutes of Health (2013–2016); Michael E. DeBakey VA Medical Center (2017–2020); Albert Einstein College of Medicine (2008); University of Minnesota (2014–2017); Memorial Hermann (2025); Saint Agnes Hospital (2020); Cleveland Clinic (2015–2022); Mayo Clinic (2020–2021); NewYork–Presbyterian Hospital (2019); The University of Texas MD Anderson Cancer Center (2016); University of Wisconsin–Madison (2013–2016); University of Kentucky (2023); Johns Hopkins University (2005–2026); Emory University (2008–2020); Medical University of South Carolina (2017); University of Idaho (2016); University of Cape Town (2022); University of California, Los Angeles (2013–2019); Oregon Health & Science University (2024); The Lundquist Institute (2016); Baylor College of Medicine (2017–2020); East Carolina University (2020); Ollscoil na Gaillimhe – University of Galway (2019); University of Washington (2013–2016); University of California, Irvine (2023); VA Palo Alto Health Care System (2017); Montana State University (2016); Esperion Therapeutics (United States) (2022); University of Michigan (2012); Columbia University Irving Medical Center (2010–2019); Johns Hopkins Medicine (2005–2026); Veterans Health Administration (2016); Hospital Israelita Albert Einstein (2012); Royal Stoke University Hospital (2019); McGill University Health Centre (2013–2015); University of Washington Medical Center (2014); Henry Ford Hospital (2019); University of Mississippi Medical Center (2015–2017); University of Alabama at Birmingham (2010–2017); Yale University (2024); University of California San Diego (2008–2016); Baptist Health South Florida (2017); VA San Diego Healthcare System (2016); University Hospital of Geneva (2013); Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (2024); Lahey Medical Center (2022); National Heart, Lung, and Blood Institute (2007–2015); Rochester General Hospital (2021–2023); CGH Medical Center (2015); Medical University of Lodz (2015); Memorial Hermann–Texas Medical Center (2025); Johns Hopkins Hospital (2005–2026); National Institutes of Health Clinical Center (2016); Sidney Kimmel Comprehensive Cancer Center (2023); Gramercy Research Group (United States) (2012); UAB Medicine (2010); Stanford Cardiovascular Institute (2017); Wake Forest University Health Sciences (2017–2023); Wake Forest University (2010–2023); McGill University (2013); Keele University (2019–2021); Drexel University (2012); Columbia University (2010–2019); University of Pennsylvania (2013); The University of Texas Southwestern Medical Center (2023); Vanderbilt University Medical Center (2024); The University of Texas Health Science Center at Houston (2025); Northeast Ohio Medical University (2017); University of California, Berkeley (2012); Stanford University (2017); Icahn School of Medicine at Mount Sinai (2008–2010)
Biomedical Subjects
Links
Biography and Research Information
Metrics
- h-index: 104
- Publications: 1199
- Citations: 63,018
Positions
-
Professor of MedicineThe Johns Hopkins University School of Medicine Medicine (Cardiology) ORCID
-
Professor of Medicine publications 2026University of Arkansas for Medical Sciences ORCID
Selected Publications
-
Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial (2025)
-
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association (2025)
-
Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association (2024)
-
Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association (2024)
-
High lipoprotein(a): Actionable strategies for risk assessment and mitigation (2024)
-
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice (2024)
-
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association (2024)
-
Sex-specific differences in cardiovascular risk factors and implications for cardiovascular disease prevention in women (2023)
-
Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society (2023)
-
Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients (2023)
-
Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity (2023)
-
Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum (2023)
-
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection (2023)
-
A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now? (2023)
-
Sleep Irregularity and Subclinical Markers of Cardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis (2023)
Collaboration Network
Top Collaborators
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
- Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
Showing 5 of 42 shared publications
- Inflammation and cardiovascular disease: From mechanisms to therapeutics
- mActive: A Randomized Clinical Trial of an Automated mHealth Intervention for Physical Activity Promotion
- Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes
- Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials
- Comparison of Carotid Plaque Score and Coronary Artery Calcium Score for Predicting Cardiovascular Disease Events: The Multi‐Ethnic Study of Atherosclerosis
Showing 5 of 37 shared publications
- 25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population
- Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA)
- Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women
- mActive: A Randomized Clinical Trial of an Automated mHealth Intervention for Physical Activity Promotion
- Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women
Showing 5 of 23 shared publications
- 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
- 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
- Inflammation and cardiovascular disease: From mechanisms to therapeutics
- Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
- mActive: A Randomized Clinical Trial of an Automated mHealth Intervention for Physical Activity Promotion
Showing 5 of 22 shared publications
- Diet Soda Intake and Risk of Incident Metabolic Syndrome and Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA)
- Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels
- Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study , ,
- Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study
- Trends in Use of High-Dose Vitamin D Supplements Exceeding 1000 or 4000 International Units Daily, 1999-2014
Showing 5 of 20 shared publications
- Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women
- Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes
- Adiposity and Incident Heart Failure and its Subtypes
- Racial Differences in Sudden Cardiac Death
- Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study
Showing 5 of 18 shared publications
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
- Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
Showing 5 of 18 shared publications
- Inflammation and cardiovascular disease: From mechanisms to therapeutics
- Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
- mActive: A Randomized Clinical Trial of an Automated mHealth Intervention for Physical Activity Promotion
- Takotsubo Syndrome in the Setting of COVID-19
- Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels
Showing 5 of 17 shared publications
- Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update
- Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update
- Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
- Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta‐Analysis
- A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?
Showing 5 of 17 shared publications
- Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women
- Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes
- Adiposity and Incident Heart Failure and its Subtypes
- Racial Differences in Sudden Cardiac Death
- Sex Steroid Hormone Concentrations and Risk of Death in US Men
Showing 5 of 16 shared publications
- Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA)
- Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women
- Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement
- Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women
- Calcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification and its Progression Among Older Adults: 10‐Year Follow‐up of the Multi‐Ethnic Study of Atherosclerosis (MESA)
Showing 5 of 16 shared publications
- Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
- Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women
- Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young Adults
- Association Between Life's Simple 7 and Noncardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis
- Association Between Resting Heart Rate and Inflammatory Biomarkers (High-Sensitivity C-Reactive Protein, Interleukin-6, and Fibrinogen) (from the Multi-Ethnic Study of Atherosclerosis)
Showing 5 of 15 shared publications
- Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
- Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
- A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
- Ten things to know about ten cardiovascular disease risk factors
- The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk
Showing 5 of 14 shared publications
- Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA)
- Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
- Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women
- Diet Soda Intake and Risk of Incident Metabolic Syndrome and Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA)
- Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study
Showing 5 of 13 shared publications
- Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update
- Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update
- Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women
- Hormone Replacement Therapy and the Cardiovascular System
- Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease
Showing 5 of 13 shared publications